Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Villard

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Transplant Immunology|September 10, 2002
Selection of unrelated bone marrow donors by serology, molecular typing and cellular assaysJean-Marie Tiercy, Jean Villard, Eddy Roosnek
Cell Transplantation|November 9, 2010
Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activityAmandine Pradier, Jakob Passweg, Jean Villard, et al.
Swiss Medical Weekly|September 1, 2012
HLA and non-HLA polymorphisms in renal transplantationStéphanie Laperrousaz, Stéphanie Tiercy, Jean Villard, et al.
Yeast (Chichester, England)|February 3, 2004
Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection markerFabienne François, Florence Chapeland-Leclerc, Jean Villard, et al.
Frontiers in Immunology|February 8, 2021
CD8+ T-Cell Repertoire in Human Leukocyte Antigen Class I-Mismatched Alloreactive Immune ResponseFlorence Bettens, Zuleika Calderin Sollet, Stéphane Buhler, et al.
HLA|July 3, 2018
Identification of seven novel HLA class I and II allelesSylvie Ferrari-Lacraz, Dominique Masson, Jean Villard, et al.
Aesthetic Surgery Journal|April 1, 2015
Long-term follow-up of cadaveric breast augmentation: what can we learn?Ali Modarressi, Jean Villard, Jean-Christophe Tille, et al.
Stem Cells and Development|April 5, 2020
Natural Killer Cell Alloreactivity Against Human Induced Pluripotent Stem Cells and Their Neuronal Derivatives into Dopaminergic NeuronsCasimir de Rham, Zuleika Calderin Sollet, Pierre Burkhard, et al.
Human Immunology|March 23, 2020
Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCTMarzieh Mansouri, Jean Villard, Mani Ramzi, et al.
Clinical Rheumatology|July 9, 2005
Pseudovasculitis and corticosteroid therapyCamillo Ribi, Denis Mauget, Jean-François Egger, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Transplant Immunology|September 10, 2002
Selection of unrelated bone marrow donors by serology, molecular typing and cellular assaysJean-Marie Tiercy, Jean Villard, Eddy Roosnek
Cell Transplantation|November 9, 2010
Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activityAmandine Pradier, Jakob Passweg, Jean Villard, et al.
Swiss Medical Weekly|September 1, 2012
HLA and non-HLA polymorphisms in renal transplantationStéphanie Laperrousaz, Stéphanie Tiercy, Jean Villard, et al.
Yeast (Chichester, England)|February 3, 2004
Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection markerFabienne François, Florence Chapeland-Leclerc, Jean Villard, et al.
Frontiers in Immunology|February 8, 2021
CD8+ T-Cell Repertoire in Human Leukocyte Antigen Class I-Mismatched Alloreactive Immune ResponseFlorence Bettens, Zuleika Calderin Sollet, Stéphane Buhler, et al.
HLA|July 3, 2018
Identification of seven novel HLA class I and II allelesSylvie Ferrari-Lacraz, Dominique Masson, Jean Villard, et al.
Aesthetic Surgery Journal|April 1, 2015
Long-term follow-up of cadaveric breast augmentation: what can we learn?Ali Modarressi, Jean Villard, Jean-Christophe Tille, et al.
Stem Cells and Development|April 5, 2020
Natural Killer Cell Alloreactivity Against Human Induced Pluripotent Stem Cells and Their Neuronal Derivatives into Dopaminergic NeuronsCasimir de Rham, Zuleika Calderin Sollet, Pierre Burkhard, et al.
Human Immunology|March 23, 2020
Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCTMarzieh Mansouri, Jean Villard, Mani Ramzi, et al.
Clinical Rheumatology|July 9, 2005
Pseudovasculitis and corticosteroid therapyCamillo Ribi, Denis Mauget, Jean-François Egger, et al.
Pageof 11